| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 951 | 3.879 | 3.538 | 0 | 4.549 | 7.840 |
| Total Income - EUR | - | - | - | - | 951 | 3.879 | 3.538 | 0 | 4.549 | 7.841 |
| Total Expenses - EUR | - | - | - | - | 260 | 1.124 | 3.117 | 540 | 2.229 | 2.560 |
| Gross Profit/Loss - EUR | - | - | - | - | 691 | 2.755 | 421 | -540 | 2.320 | 5.280 |
| Net Profit/Loss - EUR | - | - | - | - | 662 | 2.646 | 327 | -540 | 1.874 | 4.385 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Alimedmys Orl S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 26 | 0 | 0 | 0 | 0 | 1.368 |
| Current Assets | - | - | - | - | 689 | 3.522 | 5.838 | 344 | 4.640 | 6.558 |
| Inventories | - | - | - | - | 26 | 0 | 0 | 0 | 0 | 472 |
| Receivables | - | - | - | - | 0 | 0 | 14 | 14 | 2.427 | 1.865 |
| Cash | - | - | - | - | 663 | 3.522 | 5.824 | 330 | 2.213 | 4.222 |
| Shareholders Funds | - | - | - | - | 704 | 3.337 | 3.590 | -492 | 1.384 | 4.433 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 11 | 185 | 2.248 | 835 | 3.257 | 3.493 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Alimedmys Orl S.r.l.